Cytokine profile and proviral load among Japanese immigrants and non-Japanese infected with HTLV-1 in a non-endemic area of Brazil.
João Américo Domingos, Luana Silva Soares, Larissa M Bandeira, Camila Mareti Bonin, Ana C P Vicente, Louise Zanella, Marco Antonio Moreira Puga, Inês Aparecida Tozetti, Ana Rita Coimbra Motta-Castro, Rivaldo Venâncio da Cunha
Author Information
João Américo Domingos: Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Luana Silva Soares: Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Larissa M Bandeira: Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Camila Mareti Bonin: Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Ana C P Vicente: Oswaldo Cruz Institute, Rio de Janeiro, Brazil.
Louise Zanella: Oswaldo Cruz Institute, Rio de Janeiro, Brazil.
Marco Antonio Moreira Puga: Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Inês Aparecida Tozetti: Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Ana Rita Coimbra Motta-Castro: Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Rivaldo Venâncio da Cunha: Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
The lifetime risk of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) development differs among ethnic groups. To better understand these differences, this prospective cohort study was conducted to investigate the cytokine profile and the HTLV-1 proviral load (PVL) in Japanese and non-Japanese populations with HAM/TSP and asymptomatic carriers (ACs). The serum IL-2, IL-4, IL-6, IL-10, IL-17, TNF-α, and IFN-γ levels were quantified using the Cytometric Bead Array in 40 HTLV-1-infected patients (11 HAM/TSP and 29 ACs) and 18 healthy controls (HCs) in Brazil. Among ACs, 15 were Japanese descendants and 14 were non-Japanese. Of 11 patients with HAM/TSP, only one was a Japanese descendant. The HTLV-1 PVL was quantified by real-time PCR. The HTLV-1 PVL was 2.7-fold higher in HAM/TSP patients than ACs. Regardless of the clinical outcome, the PVL was significantly higher in patients younger than 60 years than older patients. The HAM/TSP and ACs had higher IL-10 serum concentrations than that of HCs. The ACs also showed higher IL-6 serum levels than those of HCs. According to age, the IL-10 and IL-6 levels were higher in ACs non-Japanese patients older than 60 years. HAM/TSP patients showed a positive correlation between IL-6 and IL-17 and a negative correlation between the PVL and IL-17 and IFN-γ. In the all ACs, a significant positive correlation was observed between IL-2 and IL-17 and a negative correlation was detected between IL-10 and TNF-α. Only 6.25% of the Japanese patients were symptomatic carriers, compared with 41.67% of the non-Japanese patients. In conclusion, this study showed that high levels of HTLV-1 PVL was intrinsicaly associated with the development of HAM/TSP. A higher HTLV-1 PVL and IL10 levels found in non-Japanese ACs over 60 years old, which compared with the Japanese group depicts that the ethnic background may interfere in the host immune status. More researches also need to be undertaken regarding the host genetic background to better understand the low frequency of HAM/TSP in Japanese HTLV-1-infected individuals.
